Avanos Medical Inc (AVNS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avanos Medical Inc (AVNS) has a cash flow conversion efficiency ratio of -0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.30 Million) by net assets ($782.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Avanos Medical Inc (AVNS) defensive interval to measure how many days the company can operate on defensive assets alone.
Avanos Medical Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Avanos Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Avanos Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avanos Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Corbion NV
AS:CRBN
|
0.155x |
|
Reit 1
TA:RIT1
|
0.006x |
|
Pennant Group Inc
NASDAQ:PNTG
|
-0.009x |
|
Aurisco Pharmaceutical Co Ltd
SHG:605116
|
N/A |
|
RLJ Lodging Trust
NYSE:RLJ
|
0.029x |
|
Catalyst Metals Ltd
AU:CYL
|
0.205x |
|
NH SPAC 8
KQ:218410
|
0.065x |
|
Nanjing Xinjiekou Department Store Co Ltd
SHG:600682
|
0.009x |
Annual Cash Flow Conversion Efficiency for Avanos Medical Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of Avanos Medical Inc from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Avanos Medical Inc (AVNS) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $778.20 Million | $74.70 Million | 0.096x | -21.02% |
| 2024-12-31 | $828.50 Million | $100.70 Million | 0.122x | +363.78% |
| 2023-12-31 | $1.24 Billion | $32.40 Million | 0.026x | -62.77% |
| 2022-12-31 | $1.29 Billion | $90.90 Million | 0.070x | +2.46% |
| 2021-12-31 | $1.27 Billion | $87.30 Million | 0.069x | +3553.25% |
| 2020-12-31 | $1.26 Billion | $-2.50 Million | -0.002x | +96.62% |
| 2019-12-31 | $1.27 Billion | $-74.50 Million | -0.059x | +47.54% |
| 2018-12-31 | $1.30 Billion | $-145.60 Million | -0.112x | -194.60% |
| 2017-12-31 | $1.22 Billion | $144.20 Million | 0.119x | -30.72% |
| 2016-12-31 | $1.10 Billion | $188.80 Million | 0.171x | +85.16% |
| 2015-12-31 | $1.06 Billion | $97.60 Million | 0.092x | -6.75% |
| 2014-12-31 | $1.49 Billion | $147.90 Million | 0.099x | -7.86% |
| 2013-12-31 | $2.08 Billion | $223.80 Million | 0.108x | +9.22% |
| 2012-12-31 | $2.06 Billion | $202.60 Million | 0.099x | -- |
| 2011-12-31 | $0.00 | $139.60 Million | x | -- |
About Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including… Read more